ArticleBMC infectious diseases2026
Scaling trachoma surveillance in endemic areas using machine learning.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTrachoma remains a leading infectious cause of blindness in endemic regions despite progress towards global elimination. Accurate and scalable diagnosis remains challenging in areas with limited ophthalmic expertise. We developed and evaluated a reproducible transfer learning model using eyelid image-based data.
methodsWe retrospectively analysed anonymised inner eyelid photographs collected from trachoma prevalence surveys conducted in Ethiopia, Tanzania, Australia, Solomon Islands, Colombia, the Gambia, and Guatemala (n = 572 images). Images were categorized as trachoma (n = 251) or not trachoma (n = 321) based on consensus grades from the Tropical Data certified graders. Data were processed and analysed in R (version 4.4.1) using the keras and tensorflow packages interfaced with Python (version 3.10) through reticulate. A ResNet50 convolutional neural network pretrained on ImageNet was fine-tuned for binary classification. The model was trained for up to 30 epochs with early stopping and adaptive learning-rate reduction. Performance on a held-out validation set (n = 62, 12%) was evaluated using accuracy, sensitivity, specificity, and Cohen's κ.
resultsThe ResNet50 model achieved an overall accuracy of 85.4% (95% CI 76.3-92%) on the validation set. The model achieved a sensitivity of 80.9% for detecting trachoma and a specificity of 90.5% for correctly identifying non-trachoma eyes. Agreement between predictions and grader labels was substantial (κ = 0.71, 95% CI 0.58-0.84).
conclusionOur findings demonstrate the feasibility of using a reproducible R-based deep learning pipeline for automated trachoma classification in large-scale surveys. These findings demonstrate the feasibility of automated trachoma classification using a transfer-learning framework. Larger datasets will be required before operational deployment in surveillance programmes. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.